The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy
Abstract
BACKGROUND: Intake of supplements containing iron or a combination of iron and folic acid by pregnant women may improve maternal health and pregnancy outcomes. Recently, intermittent supplementation regimens have been proposed as alternatives to daily regimens. OBJECTIVES: To assess the effectiveness and safety of daily and intermittent use of iron or iron+folic acid supplements by pregnant women. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (March 2009) and contacted relevant organisations for the identification of ongoing and unpublished studies. SELECTION CRITERIA: All randomised or quasi-randomised trials evaluating the effect of supplementation with iron or iron+folic acid during pregnancy. DATA COLLECTION AND ANALYSIS: We assessed the methodological quality of trials using the standard Cochrane criteria. Two authors independently assessed which trials to include in the review and one author extracted data. MAIN RESULTS: We included 49 trials, involving 23,200 pregnant women. Overall, the results showed significant heterogeneity across most prespecified outcomes and were analysed assuming random-effects. The trials provided limited information related to clinical maternal and infant outcomes.Overall, daily iron supplementation was associated with increased haemoglobin levels in maternal blood both before and after birth and reduced risk of anaemia at term. These effects did not differ significantly between women receiving intermittent or daily iron or iron+folic acid supplementation. Women who received daily prenatal iron supplementation with or without folic acid were less likely to have iron deficiency at term as defined by current cut-off values than those who received no treatment or placebo. Side effects and haemoconcentration (a haemoglobin level greater than 130 g/L) were more common among women who received daily iron or iron+folic acid supplementation than among those who received no treatment or placebo. The risk of haemoconcentration during the second and third trimester was higher among those on a daily regimen of iron supplementation. The clinical significance of haemoconcentration remains uncertain. AUTHORS' CONCLUSIONS: Universal prenatal supplementation with iron or iron+folic acid provided either daily or weekly is effective to prevent anaemia and iron deficiency at term. We found no evidence, however, of the significant reduction in substantive maternal and neonatal adverse clinical outcomes (low birthweight, delayed development, preterm birth, infection, postpartum haemorrhage). Associated side effects and particularly haemoconcentration during pregnancy may suggest the need for revising iron doses and schemes of supplementation during pregnancy and adjust preventive iron supplementation recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
5 retracted
Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects
Lumley, J., Watson, L., Watson, M., & Bower, C. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001056 · Cited by 388
RetractedIron supplementation in pregnancy
Mahomed, K. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000117 · Cited by 123
RetractedIron and folate supplementation in pregnancy
Mahomed, K. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001135 · Cited by 88
RetractedVitamin A supplementation during pregnancy
van den Broek, N. R., Kulier, R., Gülmezoglu, A. M., & Villar, J. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001996 · Cited by 66
RetractedFolate supplementation in pregnancy
Mahomed, K. (1997) · doi:10.1002/14651858.cd000183 · Cited by 35
RetractedCochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Trumbo (2001) · doi:10.1016/s0002-8223(01)00078-5 · Cited by 4,852
Nutrition Board. Panel on Micronutrients (2001) · Medical Entomology and Zoology · Cited by 1,675
Effective Care in Pregnancy and Childbirth
Newton, E. (1990) · Journal of Human Lactation · doi:10.1177/089033449000600329 · Cited by 985
Recommendations to Prevent and Control Iron Deficiency in the United States: (547762006-001)
(1998) · PsycEXTRA Dataset · doi:10.1037/e547762006-001 · Cited by 815
Cited by
Anaemia in low-income and middle-income countries
Balarajan, Y., Ramakrishnan, U., Özaltin, E., Shankar, A. H., & Subramanian, S. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62304-5 · Cited by 1,304
Haider, B. A., Olofin, I., Wang, M., Spiegelman, D., Ezzati, M., Fawzi, W. W., & on behalf of Nutrition Impact Model Study Group (anaemia) (2013) · BMJ · doi:10.1136/bmj.f3443 · Cited by 871
Effects and safety of periconceptional oral folate supplementation for preventing birth defects
De-Regil, L. M., Peña-Rosas, J. P., Fernández-Gaxiola, A. C., & Rayco-Solon, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007950.pub3 · Cited by 784
Self-citationDaily oral iron supplementation during pregnancy
Peña-Rosas, J. P., De-Regil, L. M., Dowswell, T., & Viteri, F. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004736.pub4 · Cited by 615
Self-citationUK guidelines on the management of iron deficiency in pregnancy
Pavord, S., Myers, B., Robinson, S., Allard, S., Strong, J., Oppenheimer, C., & on behalf of the British Committee for Standards in Haematology (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.09012.x · Cited by 606
Metadata
- Authors
- Peña-Rosas, J. P., & Viteri, F. E.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2009-10-07
- Issue
- 4
- Pages
- CD004736-CD004736
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W2123637750
- Cited by
- 279
- References
- 230
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy. https://app.cochat.ai/papers/10.1002/14651858.cd004736.pub3
- The paper
- Peña-Rosas, J. P., & Viteri, F. E. (2009). Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd004736.pub3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.